CI

At a glance

ClinicalIndex Comparison Record
Phase 1Completed· 165 enrolled
Drug / intervention
Tranexamic acid +1 moredrug
Likely dose
Tranexamic acid 1000 mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT06920264
NCT06920264Phase 1Completed

Effect of Tranexamic Acid (TXA) Administered Prior to Shoulder Arthroscopy on Postoperative Pain Medication Usage: A Randomized Controlled Trial

St. Louis Joint Replacement Institute·interventional·Posted Apr 9, 2025·Updated Apr 9, 2025

In Brief

A Phase 1 clinical trial evaluating Tranexamic acid and placebo for This Study Will Evaluate Whether TXA Reduces Pain. Completed, enrolled 165 participants across 1 site.

Detailed Summary

To our knowledge, no studies examining the use of TXA after shoulder arthroscopy in an outpatient setting have been published. This study will evaluate whether TXA reduces pain as measured by opioid consumption and a visual analog scale for pain (VAS) for the first 72 hours after surgery. Secondary outcomes will examine whether patients were satisfied overall with their postoperative pain control, whether the time to first opioid use is increased, and whether the surgeon perceives improved surgical visualization in patients who received TXA. We will also examine the number of times pump pressure was increased during the procedure to improve visualization.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States
Collaborators--

Timeline

Phase 1CompletedFinished
20222023202420252026
First PostedApr 9, 2025
Enrollment StartJul 1, 2021
Primary CompletionSep 8, 2024
Study CompletionSep 30, 2024
TodayJul 2, 2026
Enrollment to primary: 3.2 yearsPosted 1.2 years ago

Interventions

Tranexamic aciddrug

A total of 150 participants will be enrolled and randomized 1:1 to receive either a standard dose of TXA (1000 mg) or an equivalent volume of placebo (normal saline, NS) at the time of surgery. .

placeboother

saline